Your browser doesn't support javascript.
loading
Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study.
Sulaj, Alba; Kopf, Stefan; von Rauchhaupt, Ekaterina; Kliemank, Elisabeth; Brune, Maik; Kender, Zoltan; Bartl, Hannelore; Cortizo, Fabiola Garcia; Klepac, Katarina; Han, Zhe; Kumar, Varun; Longo, Valter; Teleman, Aurelio; Okun, Jürgen G; Morgenstern, Jakob; Fleming, Thomas; Szendroedi, Julia; Herzig, Stephan; Nawroth, Peter P.
Afiliação
  • Sulaj A; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Kopf S; German Center of Diabetes Research (DZD), Neuherberg, Germany.
  • von Rauchhaupt E; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Kliemank E; German Center of Diabetes Research (DZD), Neuherberg, Germany.
  • Brune M; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Kender Z; German Center of Diabetes Research (DZD), Neuherberg, Germany.
  • Bartl H; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Cortizo FG; German Center of Diabetes Research (DZD), Neuherberg, Germany.
  • Klepac K; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Han Z; Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Center Munich, Neuherberg, Germany.
  • Kumar V; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Longo V; German Center of Diabetes Research (DZD), Neuherberg, Germany.
  • Teleman A; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Okun JG; German Cancer Research Center (DKFZ), Division of Signal Transduction in Cancer and Metabolism, Heidelberg, Germany.
  • Morgenstern J; Institute for Diabetes and Cancer, Helmholtz Center Munich, Neuherberg, Germany.
  • Fleming T; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Szendroedi J; Department of Endocrinology, Diabetology, Metabolism and Clinical Chemistry (Internal Medicine 1), Heidelberg University Hospital, Heidelberg, Germany.
  • Herzig S; Longevity Institute, School of Gerontology, and Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.
  • Nawroth PP; FIRC Institute of Molecular Oncology, Italian Foundation for Cancer Research Institute of Molecular Oncology, Milan, Italy.
J Clin Endocrinol Metab ; 107(8): 2167-2181, 2022 07 14.
Article em En | MEDLINE | ID: mdl-35661214
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Diabetes Mellitus Tipo 2 / Nefropatias Diabéticas Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article